2022粵港澳(ao)大灣(wan)(wan)區生(sheng)物(wu)(wu)醫(yi)(yi)藥(yao)(yao)企(qi)業十強(qiang)榜(bang)(bang)單依托“時代數(shu)據(ju)生(sheng)物(wu)(wu)醫(yi)(yi)藥(yao)(yao)企(qi)業數(shu)據(ju)庫”，通(tong)過(guo)大數(shu)據(ju)分(fen)(fen)析，對總(zong)部位于粵港澳(ao)大灣(wan)(wan)區的生(sheng)物(wu)(wu)醫(yi)(yi)藥(yao)(yao)企(qi)業2022年上半年營業收入(ru)、扣非(fei)后歸母凈利(li)潤、研發投入(ru)、總(zong)資產(chan)、經營活動現金流、貨幣資金、期末存(cun)貨、員(yuan)工總(zong)數(shu)等數(shu)據(ju)進行建(jian)模(mo)分(fen)(fen)析，綜合評分(fen)(fen)。白云山位居榜(bang)(bang)首，中國(guo)生(sheng)物(wu)(wu)制藥(yao)(yao)位居榜(bang)(bang)單第二(er)位，健康元位居榜(bang)(bang)單第三(san)位。